MiR-105-3p acts as an oncogene to promote the proliferation and metastasis of breast cancer cells by targeting GOLIM4
Abstract Background Dysregulated miRNAs are involved in carcinogenesis of the breast and may be used as prognostic biomarkers and therapeutic targets during the cancer process. The purpose of this study was to explore the effect of miR-105-3p on the tumourigenicity of breast cancer and its underlyin...
Main Authors: | Bo Lin, Chunhua Liu, Enyi Shi, Qiu Jin, Wenhui Zhao, Juan Wang, Runyuan Ji |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-07909-2 |
Similar Items
-
RBFOX2/GOLIM4 Splicing Axis Activates Vesicular Transport Pathway to Promote Nasopharyngeal Carcinogenesis
by: Chun‐Ling Luo, et al.
Published: (2021-08-01) -
miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer
by: Hao-Yi Li, et al.
Published: (2017-12-01) -
The Diverse Oncogenic and Tumor Suppressor Roles of microRNA-105 in Cancer
by: Jie Li, et al.
Published: (2019-06-01) -
Plasma miR‐1247‐5p, miR‐301b‐3p and miR‐105‐5p as potential biomarkers for early diagnosis of non‐small cell lung cancer
by: Xiaohan Dong, et al.
Published: (2021-02-01) -
miR-105 Promotes the Progression and Predicts the Prognosis for Oral Squamous Cell Carcinoma (OSCC)
by: Zhang HY, et al.
Published: (2020-11-01)